Allstate Corporation’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Allstate Corporation's CYTK Position: Q3 2026 in Review
Allstate Corporation reduced its Cytokinetics (CYTK) stake by 42% in Q3 2026, selling an estimated $535K and leaving 9,873 shares worth $651K. The position accounts for 0.01% of the portfolio, ranked #724.
Allstate Corporation first reported a position in CYTK in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.44M in Q2 2026. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Allstate Corporation held 9,873 shares of Cytokinetics worth $651K as of Q3 2026.
- Allstate Corporation sold 7,016 Cytokinetics shares in Q3 2026, an estimated $535K.
- Cytokinetics made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #724 holding.
- Allstate Corporation first reported a position in Cytokinetics in Q1 2026 and has held it in 3 quarters since.
- Allstate Corporation's Cytokinetics position peaked at $1.44M in Q2 2026.
- 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.